指南与共识肺结节与肺癌

医生对肺结节恶性概率的评估准确性及指南依从性

Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
指南 / 共识 · Chest · 2017-01-20

该研究评估337例肺结节患者的医生预判恶性概率与两种经验证风险模型的表现,并比较后续检查是否符合指南。1年恶性患病率为47%;但61%病例的下一步检查未遵循指南推荐。

要点

  • 医生对肺结节恶性概率的临床判断AUC达0.85,优于两种经验证风险模型。
  • 61%的病例在选择下一步检查时未遵循指南推荐。
  • 低概率组中52%被更积极处理,高风险组中75%被更保守处理,均偏离指南。

核心结论

  • 医生对肺结节恶性概率的临床评估比经验证的结节预测计算器更准确。
  • 尽管临床直觉准确,医生在选择下一步诊断检查时未遵循指南推荐。
  • 为优化患者管理,需关注指南的细化、实施和推广。

研究设计与样本

  • 研究纳入337例肺结节患者,评估337名医生的预判恶性概率及两种经验证风险模型评估。
  • 以最终诊断为依据比较医生评估与风险模型的表现,并按低、中、高风险分层评估下一步检查选择。

主要发现

  • 1年恶性患病率为47%(n=158)。
  • 61%(n=205)的病例在选择下一步检查时未遵循指南推荐。
  • 低概率组中52%(n=13)被更积极处理(PET或活检),12%(n=3)因良性病变接受活检。
  • 高风险组中多数(n=103[75%])被更保守处理;良性病变中92%(n=22)接受更保守管理(CT 20%、PET 15%、活检8%),3例(8%)接受手术。

临床怎么用

  • 对肺结节患者,医生可依据临床判断评估恶性概率,其准确性优于经验证风险模型。
  • 需对照指南推荐选择下一步检查,减少低风险组过度检查和高风险组检查不足。
  • 应加强指南的细化、实施与推广以优化肺结节管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The annual incidence of pulmonary nodules is estimated at 1.57 million. Guidelines recommend using an initial assessment of nodule probability of malignancy (pCA). A previous study found that despite this recommendation, physicians did not follow guidelines. METHODS: Physician assessments (N = 337) and two previously validated risk model assessments of pretest probability of cancer were evaluated for performance in 337 patients with pulmonary nodules based on final diagnosis and compared. Physician-assessed pCA was categorized into low, intermediate, and high risk, and the next test ordered was evaluated. RESULTS: The prevalence of malignancy was 47% (n = 158) at 1 year. Physician-assessed pCA performed better than nodule prediction calculators (area under the curve, 0.85 vs 0.75; P < .001 and .78; P = .0001). Physicians did not follow indicated guidelines when selecting the next test in 61% of cases (n = 205). Despite recommendations for serial CT imaging in those with low pCA, 52% (n = 13) were managed more aggressively with PET imaging or biopsy; 12% (n = 3) underwent biopsy procedures for benign disease. Alternatively, in the high-risk category, the majority (n = 103 [75%]) were managed more conservatively. Stratified by diagnosis, 92% (n = 22) with benign disease underwent more conservative management with CT imaging (20%), PET scanning (15%), or biopsy (8%), although three had surgery (8%). CONCLUSIONS: Physician assessment as a means for predicting malignancy in pulmonary nodules is more accurate than previously validated nodule prediction calculators. Despite the accuracy of clinical intuition, physicians did not follow guideline-based recommendations when selecting the next diagnostic test. To provide optimal patient care, focus in the areas of guideline refinement, implementation, and dissemination is needed.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Tanner NT, Porter A, Gould MK, et al. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017. PMID: 28115167. doi:10.1016/j.chest.2017.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。